National Institute of Dental and Craniofacial Research (NIDCR) grantees and colleagues add some thought-provoking data with the results of the first extensive study of DNA methylation patterns in healthy salivary glands and 4 salivary tumor types (pleomorphic adenoma, adenoid cystic carcinoma, mucoepidermoid carcinoma, and salivary duct carcinoma). DNA methylation occurs when a methyl group attaches often to the promoter region of a gene. The methyl tag alters the gene’s ability to interact with needed transcription regulators, thereby turning off the gene. Although DNA methylation often occurs naturally to make one inherited gene dominant over another, tumor cells often co-opt the methylation process early in their development to shut down growth-inhibiting tumor suppressor genes and enable their aberrant behavior. In the study, the scientists evaluated the methylation patterns of 19 tumor suppressor genes in a total of 95 tissue samples (17 normal, 78 from either benign or malignant tumors). The researchers discovered surprising variation in the frequency and quantity of methylation among the different tumor types. The same held true for the healthy tissue. Indeed, the average level of methylation in the panel of tumor suppressor genes was comparable in healthy tissue and 2 of the 4 tumor types. However, the study did produce a few leads. They found that several tumor suppressor genes were associated with malignant salivary gland tumors, especially for salivary duct carcinoma. Further study is needed to pin down or rule out these leads.
(Source: NIDCR, Science News in Brief, July 20, 2010)